非编码RNA向疗法:一篇最先进的研究报告
1Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
International journal of molecular sciences
|April 13, 2024
概括
非编码RNAs (ncRNAs) 显示出作为心血管疾病和癌症等疾病的治疗点的希望. 研究正在推进基于miRNA的药物,解决临床应用的交付和特异性方面的挑战.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非编码RNAs (ncRNAs),包括microRNAs (miRNAs) 和长非编码RNAs (lncRNAs),越来越多地被认为是它们在疾病发病过程中的作用.
- 它们的失调与各种疾病有关,特别是心血管疾病和癌症,为新的治疗策略提供了机会.
研究的目的:
- 审查ncRNAs作为治疗点的当前景观.
- 讨论基于miRNA的药物开发的进展和挑战,特别是针对心血管疾病.
- 探索未来的前景和ncRNA治疗的临床翻译的最新进展.
主要方法:
- 文献综述和关于ncRNAs在疾病中的当前研究的综合.
- 对基于miRNA的治疗方法的临床前和临床数据的分析.
- 讨论ncRNA药物的特异性,输送和耐受性方面的挑战.
主要成果:
- ncRNAs,特别是miRNAs,正在成为可行的药物标,在临床前和临床研究中取得了重大进展.
- 心血管疾病是基于miRNA的疗法显示有前途的关键领域,解决了传统治疗的局限性.
- 在识别,表征和操纵miRNA方面的进展正在为临床应用铺平道路.
结论:
- 准ncRNAs为各种疾病提供了一个有希望的治疗途径,包括心血管疾病.
- 克服与特异性,输送和耐受性相关的挑战对于基于miRNA的药物的成功临床转化至关重要.
- 持续的研究和开发对于充分实现ncRNA疗法的潜力至关重要.
更多相关视频
11:57Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
Published on: April 21, 2016
6.7K
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
7.9K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
